1.
Cao
Z
.
Causal relationships between gut microbiotas, blood metabolites, and neuroendocrine tumors: a mediated Mendelian randomization study
.
Neuroendocrinology
.
2024
;
114
(
11
):
981
992
.
2.
Massironi
S
,
Sciola
V
,
Peracchi
M
,
Ciafardini
C
,
Spampatti
MP
,
Conte
D
.
Neuroendocrine tumors of the gastro-entero-pancreatic system
.
World J Gastroenterol
.
2008
;
14
(
35
):
5377
84
.
3.
Fraenkel
M
,
Kim
M
,
Faggiano
A
,
de Herder
WW
,
Valk
GD
;
Knowledge NETwork
.
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
.
Endocr Relat Cancer
.
2014
;
21
(
3
):
R153
63
.
4.
Boyar Cetinkaya
R
,
Aagnes
B
,
Thiis-Evensen
E
,
Tretli
S
,
Bergestuen
DS
,
Hansen
S
.
Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010
.
Neuroendocrinology
.
2017
;
104
(
1
):
1
10
.
5.
Dasari
A
,
Shen
C
,
Halperin
D
,
Zhao
B
,
Zhou
S
,
Xu
Y
, et al
.
Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States
.
JAMA Oncol
.
2017
;
3
(
10
):
1335
.
6.
Das
S
,
Dasari
A
.
Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences
.
Curr Oncol Rep
.
2021
;
23
(
4
):
43
.
7.
Rossi
RE
,
Massironi
S
.
The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues
.
J Clin Med
.
2022
;
11
(
13
):
3794
.
8.
Sanguedolce
F
,
Zanelli
M
,
Palicelli
A
,
Cavazza
A
,
De Marco
L
,
Zizzo
M
, et al
.
The classification of neuroendocrine neoplasms of the lung and digestive system according to WHO, 5th edition: similarities, differences, challenges, and unmet needs
.
Panminerva Med
.
2022
;
64
(
2
):
259
64
.
9.
Boyar Cetinkaya
R
,
Aagnes
B
,
Myklebust
T
,
Thiis-Evensen
E
.
Survival in neuroendocrine neoplasms; a report from a large Norwegian population-based study
.
Int J Cancer
.
2018
;
142
(
6
):
1139
47
.
10.
Alexandraki
KI
,
Spyroglou
A
,
Kykalos
S
,
Daskalakis
K
,
Kyriakopoulos
G
,
Sotiropoulos
GC
, et al
.
Changing biological behaviour of NETs during the evolution of the disease: progress on progression
.
Endocr Relat Cancer
.
2021
;
28
(
5
):
R121
40
.
11.
Feola
T
,
Centello
R
,
Sesti
F
,
Puliani
G
,
Verrico
M
,
Di Vito
V
, et al
.
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review
.
Cancers
.
2021
;
13
(
6
):
1247
.
12.
Zhang
Z
,
Li
D
,
Xie
F
,
Muhetaer
G
,
Zhang
H
.
The cause-and-effect relationship between gut microbiota abundance and carcinoid syndrome: a bidirectional Mendelian randomization study
.
Front Microbiol
.
2023
;
14
:
1291699
.
13.
Mulders
MCF
,
Audhoe
AS
,
Van Koetsveld
PM
,
Feelders
RA
,
Hofland
LJ
,
de Herder
WW
, et al
.
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature
.
Eur J Cancer
.
2024
;
197
:
113472
.
14.
Zhang
CY
,
Jiang
SJ
,
Cao
JJ
,
Xu
Y
,
Wang
XY
,
Li
R
, et al
.
Investigating the causal relationship between gut microbiota and gastroenteropancreatic neuroendocrine neoplasms: a bidirectional Mendelian randomization study
.
Front Microbiol
.
2024
;
15
:
1420167
.
15.
Sepich-Poore
GD
,
Zitvogel
L
,
Straussman
R
,
Hasty
J
,
Wargo
JA
,
Knight
R
.
The microbiome and human cancer
.
Science
.
2021
;
371
(
6536
):
eabc4552
.
16.
Picardo
SL
,
Coburn
B
,
Hansen
AR
.
The microbiome and cancer for clinicians
.
Crit Rev Oncol Hematol
.
2019
;
141
:
1
12
.
17.
Sharma
VR
,
Singh
M
,
Kumar
V
,
Yadav
M
,
Sehrawat
N
,
Sharma
DK
, et al
.
Microbiome dysbiosis in cancer: exploring therapeutic strategies to counter the disease
.
Semin Cancer Biol
.
2021
;
70
:
61
70
.
18.
González-Sánchez
P
,
DeNicola
GM
.
The microbiome(s) and cancer: know thy neighbor(s)
.
J Pathol
.
2021
;
254
(
4
):
332
43
.
19.
Wong-Rolle
A
,
Wei
HK
,
Zhao
C
,
Jin
C
.
Unexpected guests in the tumor microenvironment: microbiome in cancer
.
Protein Cell
.
2021
;
12
(
5
):
426
35
.
20.
Chen
Y
,
Wu
FH
,
Wu
PQ
,
Xing
HY
,
Ma
T
.
The role of the tumor microbiome in tumor development and its treatment
.
Front Immunol
.
2022
;
13
:
935846
.
21.
Zhou
X
,
Kandalai
S
,
Hossain
F
,
Zheng
Q
.
Tumor microbiome metabolism: a game changer in cancer development and therapy
.
Front Oncol
.
2022
;
12
:
933407
.
22.
Rajagopala
SV
,
Vashee
S
,
Oldfield
LM
,
Suzuki
Y
,
Venter
JC
,
Telenti
A
, et al
.
The human microbiome and cancer
.
Cancer Prev Res
.
2017
;
10
(
4
):
226
34
.
23.
Hu
W
,
Chen
ZM
,
Li
XX
,
Lu
L
,
Yang
GH
,
Lei
ZX
, et al
.
Faecal microbiome and metabolic signatures in rectal neuroendocrine tumors
.
Theranostics
.
2022
;
12
(
5
):
2015
27
.
24.
Vitale
G
,
Dicitore
A
,
Barrea
L
,
Sbardella
E
,
Razzore
P
,
Campione
S
, et al
.
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: are we on the highway to hell
.
Rev Endocr Metab Disord
.
2021
;
22
(
3
):
511
25
.
25.
Massironi
S
,
Facciotti
F
,
Cavalcoli
F
,
Amoroso
C
,
Rausa
E
,
Centonze
G
, et al
.
Intratumor microbiome in neuroendocrine neoplasms: a new partner of tumor microenvironment? A pilot study
.
Cells
.
2022
;
11
(
4
):
692
.
26.
Mohamed
A
,
Asa
SL
,
McCormick
T
,
Al-Shakhshir
H
,
Dasari
A
,
Mauricio
R
, et al
.
The role of the microbiome in gastroentero-pancreatic neuroendocrine neoplasms (GEP-NENs)
.
Curr Issues Mol Biol
.
2022
;
44
(
5
):
2015
28
.
27.
Kiousi
DE
,
Kouroutzidou
AZ
,
Neanidis
K
,
Karavanis
E
,
Matthaios
D
,
Pappa
A
, et al
.
The role of the gut microbiome in cancer immunotherapy: current knowledge and future directions
.
Cancers
.
2023
;
15
(
7
):
2101
.
You do not currently have access to this content.